Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sven Francque

Showing results (11-20 of 177) with videos related to

Pageof 18
Sort By:
Journal of Hepatology|July 17, 2023
Treating NASH by targeting peroxisome proliferator-activated receptorsBart Staels, Laura Butruille, Sven Francque
Gut|March 13, 2021
NAFLD in lean individuals: not a benign diseaseSven Francque, Vincent Wai-Sun Wong
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 24, 2026
Non-paired comparison of EUS-guided and transjugular liver approaches using different needles: can firm conclusions be made?Haifeng Lu, Thomas Vanwolleghem, Sven Francque
Ebiomedicine|March 27, 2024
Emerging role of ferroptosis in metabolic dysfunction-associated steatotic liver disease: revisiting hepatic lipid peroxidationCédric Peleman, Sven Francque, Tom Vanden Berghe
Annual Review of Physiology|December 16, 2015
Pathophysiology and Mechanisms of Nonalcoholic Fatty Liver DiseaseJoel T Haas, Sven Francque, Bart Staels
Journal of Hepatology|September 19, 2021
Reply to: "Intermuscular abdominal fat fraction and metabolic dysfunction-associated fatty liver disease: Does the link already exist in childhood?"Maxime Nachit, Wilhelmus J Kwanten, Sven Francque
Journal of Hepatology|February 22, 2025
Reply to: "Correspondence on <Hepatic venous pressure gradient predicts risk of hepatic decompensation and liver-related mortality in patients with MASLD>"Benedikt Silvester Hofer, Wilhelmus J Kwanten, Sven Francque
Hepatology (Baltimore, Md.)|April 28, 2016
Successful antiviral treatment of chronic hepatitis C leads to a rapid decline of liver stiffness without an early effect on spleen stiffnessWim Verlinden, Sven Francque, Peter Michielsen, et al.
Journal of Hepatology|September 1, 2024
Reply to: "MetALD accounts for a large part of what we call MASLD!"Wilhelmus J Kwanten, Benedikt Silvester Hofer, Sven Francque
World Journal of Gastroenterology|July 11, 2014
Diagnostic challenges in alcohol use disorder and alcoholic liver diseaseLuisa Vonghia, Peter Michielsen, Geert Dom, et al.
Pageof 18

Showing results (11-20 of 177) with videos related to

Sort By:
Pageof 18
Journal of Hepatology|July 17, 2023
Treating NASH by targeting peroxisome proliferator-activated receptorsBart Staels, Laura Butruille, Sven Francque
Gut|March 13, 2021
NAFLD in lean individuals: not a benign diseaseSven Francque, Vincent Wai-Sun Wong
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 24, 2026
Non-paired comparison of EUS-guided and transjugular liver approaches using different needles: can firm conclusions be made?Haifeng Lu, Thomas Vanwolleghem, Sven Francque
Ebiomedicine|March 27, 2024
Emerging role of ferroptosis in metabolic dysfunction-associated steatotic liver disease: revisiting hepatic lipid peroxidationCédric Peleman, Sven Francque, Tom Vanden Berghe
Annual Review of Physiology|December 16, 2015
Pathophysiology and Mechanisms of Nonalcoholic Fatty Liver DiseaseJoel T Haas, Sven Francque, Bart Staels
Journal of Hepatology|September 19, 2021
Reply to: "Intermuscular abdominal fat fraction and metabolic dysfunction-associated fatty liver disease: Does the link already exist in childhood?"Maxime Nachit, Wilhelmus J Kwanten, Sven Francque
Journal of Hepatology|February 22, 2025
Reply to: "Correspondence on <Hepatic venous pressure gradient predicts risk of hepatic decompensation and liver-related mortality in patients with MASLD>"Benedikt Silvester Hofer, Wilhelmus J Kwanten, Sven Francque
Hepatology (Baltimore, Md.)|April 28, 2016
Successful antiviral treatment of chronic hepatitis C leads to a rapid decline of liver stiffness without an early effect on spleen stiffnessWim Verlinden, Sven Francque, Peter Michielsen, et al.
Journal of Hepatology|September 1, 2024
Reply to: "MetALD accounts for a large part of what we call MASLD!"Wilhelmus J Kwanten, Benedikt Silvester Hofer, Sven Francque
World Journal of Gastroenterology|July 11, 2014
Diagnostic challenges in alcohol use disorder and alcoholic liver diseaseLuisa Vonghia, Peter Michielsen, Geert Dom, et al.
Pageof 18